ArticleScientific reports2026
Whole exome sequencing reveals rare DNA repair gene variants in BRCA1/2-negative Arab early-onset breast cancer patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early-onset Breast Cancer (EOBC), defined as breast cancer diagnosed at or before the age of 40 years, represents a small but clinically aggressive subset of breast cancer cases. While pathogenic variants in BRCA1/2 might explain some of this risk, many EOBC cases remain unexplained. This study aimed to investigate rare germline variants in DNA repair genes that may contribute to EOBC among BRCA1/2-negative patients of Arab ancestry. We performed germline whole exome sequencing (WES) on a cohort of 79 BRCA1/2 negative EOBC patients (median age 28 years, range 13-39). Rare variants (minor allele frequency < 1%) in 217 curated DNA repair genes were filtered and prioritized using CADD and REVEL scores. Protein structure modeling was conducted for selected novel variants to evaluate their potential impact on protein function. Seventy rare deleterious variants were identified across the analyzed DNA repair genes. Among these, five novel variants were identified in DNA2, CLK2, EME2, SWI5 and RAD51B, the latter harboring a frameshift variant indicative of loss of function. Structured modeling revealed that three novel missense variants - DNA2, CLK2 and EME2 - were predicted to introduce localized structural changes that may affect protein function. Several patients carried multiple deleterious variants, suggesting a possible polygenic contribution to EOBC predisposition. These findings expand the spectrum of rare DNA repair gene variants observed in BRCA1/2-negative early-onset breast cancer and provide candidate variants for further investigation, rather than establishing definitive causal associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.